FDA head offers guidelines for vaccine to Senate: ‘We will not cut corners in our decision-making’

WASHINGTON, DC - JUNE 30: Adm. Brett Giroir (L) of the U.S. Public Health Service, and FDA Commissioner Stephen Hahn prepare to testify at a hearing of the Senate Health, Education, Labor and Pensions Committee on June 30, 2020 in Washington, DC. The committee is examining efforts to contain the Covid-19 pandemic while putting people back to work and kids back in school. (Photo by Kevin Dietsch-Pool/Getty Images)

WASHINGTON — The head of the Food and Drug Administration says vaccine developers will be expected to study COVID-19 shots in racial minorities, the elderly, pregnant women and those with other health conditions.

FDA Commissioner Stephen Hahn outlined the guidelines for potential vaccines at a Senate hearing on reopening schools and workplaces.

Hahn says “while the FDA is committed to help expedite this work, we will not cut corners in our decision-making.”

The agency has come under criticism for granting emergency authorization to a malaria drug touted by President Donald Trump as a treatment for coronavirus. The agency revoked that designation earlier this month after studies found the drug was ineffective against the virus.

The U.S. is set to begin a 30,000-person trial of a government-created shot starting next month. Under the Trump administration’s program dubbed “Operation Warp Speed,” health officials aim to have 300 million doses on hand by January.

About 15 experimental COVID-19 vaccines are in various stages of testing worldwide. There is no guarantee that any will prove effective.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.